Filtered By:
Source: Cardiovascular Diabetology

This page shows you your search results in order of date. This is page number 6.

Order by Relevance | Date

Total 81 results found since Jan 2013.

Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study
Conclusions: IL-6 and actA may provide prognostic information on CV events and mortality in T2D beyond conventional CV risk factors.Trial registrationClinicalTrials.gov: NCT00133718
Source: Cardiovascular Diabetology - August 30, 2013 Category: Cardiology Authors: Anne Pernille OfstadLars GullestadElsa OrvikSvend AakhusKnut EndresenThor UelandPål AukrustMorten FagerlandKåre BirkelandOdd Erik Johansen Source Type: research

Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Baerum Cardiovascular Diabetes (ABCD) cohort study
Conclusions: IL-6 and actA may provide prognostic information on CV events and mortality in T2D beyond conventional CV risk factors.Trial registrationClinicalTrials.gov: NCT00133718
Source: Cardiovascular Diabetology - August 30, 2013 Category: Cardiology Authors: Anne Pernille OfstadLars GullestadElsa OrvikSvend AakhusKnut EndresenThor UelandPål AukrustMorten FagerlandKåre BirkelandOdd Erik Johansen Source Type: research

Comparative effect of clopidogrel and aspirin versus aspirin alone on laboratory parameters: a retrospective, observational, cohort study
Conclusion: Our findings suggested that hematological adverse effects may be greater with combination therapy of clopidogrel plus aspirin than with aspirin monotherapy.
Source: Cardiovascular Diabetology - June 14, 2013 Category: Cardiology Authors: Yasuo TakahashiYayoi NishidaTomohiro NakayamaSatoshi Asai Source Type: research

Diabetes severity and the role of leisure time physical exercise on cardiovascular mortality: the Nord-Trlatin small letter o with strokendelag Health study (HUNT), Norway
Conclusions: The data suggest a more favourable effect of exercise in people with diabetes who used medication than in those who did not, suggesting that physical exercise should be encouraged as a therapeutic measure additional to medical treatment.
Source: Cardiovascular Diabetology - June 6, 2013 Category: Cardiology Authors: Børge MoeLiv Berit AugestadTom Nilsen Source Type: research

Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy ¿ an analysis of the DiaRegis registry
Conclusion: The present study suggests, that co-morbidity but not average glycaemic control reduces health related quality of life in type 2 diabetes mellitus.
Source: Cardiovascular Diabetology - March 20, 2013 Category: Cardiology Authors: Jürgen WasemPeter BramlageAnselm GittChristiane BinzMichael KreklerEvelin DeegDiethelm Tschöpe Source Type: research

Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy -- an analysis of the DiaRegis registry
Conclusion: The present study suggests, that co-morbidity but not average glycaemic control reduces health related quality of life in type 2 diabetes mellitus.
Source: Cardiovascular Diabetology - March 20, 2013 Category: Cardiology Authors: Jürgen WasemPeter BramlageAnselm GittChristiane BinzMichael KreklerEvelin DeegDiethelm Tschöpe Source Type: research